v3.22.2.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 04, 2022
May 14, 2020
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2022
Dec. 01, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Proceeds from issuance of common stock           $ 1,031    
Employee benefits and share based compensation     $ 701   $ 161 $ 1,395 $ 319    
Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Warrants exercised on cashless     415,664     415,664      
Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Exchange of shares         271,811   271,811    
2013 Beyond Air Equity Incentive Plan [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock option vesting term, description       The vesting terms of the options issued under the 2013 BA Plan are generally four years and expire in ten years from the grant date          
Stock option vesting term           10 years      
Stock option shares authorized for issuance     7,600,000     7,600,000     2,000,000
Number of shares available for grant     321,761     321,761      
Weighted average remaining contractual term           7 years 7 months 6 days   8 years 1 month 6 days  
Share based compensation arrangements by share based payment award options grants in period weighted average exercise price           $ 7.95      
Warrants exercised on cashless           15,000      
2013 Beyond Air Equity Incentive Plan [Member] | Unvested Stock Options [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Employee Service Share Based Compensation     $ 7,700     $ 7,700      
Weighted average remaining contractual term           1 year 4 months 24 days      
Share based compensation arrangements by share based payment award options grants in period weighted average exercise price           $ 5.98 $ 7.92    
2021 Beyond Cancer Ltd Equity Incentive Plan [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock option vesting term, description           The vesting terms of the options issued under the 2021 BC Plan are generally four years and expire in ten years from the grant date      
Stock option vesting term           10 years      
Number of shares available for grant     157,500     157,500      
Weighted average remaining contractual term           9 years 3 months 18 days   9 years 3 months 18 days  
Share based compensation arrangements by share based payment award options grants in period weighted average exercise price           $ 10.00      
Warrants exercised on cashless                
2021 Beyond Cancer Ltd Equity Incentive Plan [Member] | Unvested Stock Options [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Employee Service Share Based Compensation     $ 10,300     $ 10,300      
Weighted average remaining contractual term           1 year 9 months 18 days      
Share based compensation arrangements by share based payment award options grants in period weighted average exercise price           $ 8.28      
Stock Purchase Agreement [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Net proceeds   $ 40,000              
Sale of stock price per share   $ 0.25              
Proceeds from issuance of common stock           $ 0 $ 1,000    
Sale of stock           0 200,000    
Shares available under agreement, value           $ 18,100      
At The Market Equity Offering [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Net proceeds     $ 200   $ 15,000 $ 200 $ 22,400    
Sale of stock     19,300   1,659,664 19,300 2,899,069    
Proceeds from issuance sale of equity $ 50,000         $ 49,800      
Fees paid percentage 3.00%